Home

    You are here

    • You are here:
      • Home >

28
Jun
Tue, 28/06/2022 - 12:03
RESEARCH

Antiretroviral drug improves cognition in mouse model of Down syndrome

Antiretroviral drug improves cognition in mouse model of Down syndrome

Targeting retrotransposons is an unexplored option for people Down syndrome that this work demonstrates is of great therapeutic interest.

  • Group page
  • Research lines
  • Publications
Staff Scientist
Raúl Burgos Castellanos

Staff Scientist
Raúl Burgos Castellanos

Short CV

2022 – Staff Scientist, Center for Genomic Regulation (CRG), Barcelona (Spain)
2015 – Post-doctoral fellow, Center for Genomic Regulation (CRG), Barcelona (Spain)
2010 – Post-doctoral fellow, University of Washington (UW), Seattle (USA)
2009 – Ph.D in Biotechnology, Universitat Autònoma de Barcelona (UAB), Bellaterra (Spain)
2006 – M.Sc. in Biotechnology, Universitat Autònoma de Barcelona (UAB), Bellaterra (Spain)

24
May
Tue, 24/05/2022 - 15:00
FUNDING

ERC funds CRG ‘designer cytokine therapy’ project

ERC funds CRG ‘designer cytokine therapy’ project

A new Proof of Concept Grant will aid the exploration of new methods that improve the therapeutic effectiveness of cytokines

23
May
Mon, 23/05/2022 - 12:02
RESEARCH

Turning X chromosome “off and on again” critical for oocyte development

Turning X chromosome “off and on again” critical for oocyte development

The findings could pave the way for generating artificial oocytes in the laboratory

19
May
Thu, 19/05/2022 - 09:29
RESEARCH
OUTREACH

Citizen science reveals first comprehensive snapshot of the oral microbiome

Citizen science reveals first comprehensive snapshot of the oral microbiome

Research means that in the future a saliva test could be as informative and routinely used as blood tests

16
May
Mon, 16/05/2022 - 12:13
INSTITUTIONAL

EMERALD, the first European-wide PhD program for medical doctors, opens 2nd call for applications

EMERALD, the first European-wide PhD program for medical doctors, opens 2nd call for applications

The deadline for applications is the 28th of August at 5PM Central European Summer Time.

12
May
Thu, 12/05/2022 - 12:17
RESEARCH

Catalan collaboration helps end ‘diagnostic odyssey’ for rare disease patients

Catalan collaboration helps end ‘diagnostic odyssey’ for rare disease patients

New tool provides a second chance for patients who have exhausted the routine clinical pathway

26
Apr
Tue, 26/04/2022 - 10:34
RESEARCH
OUTREACH

GENIGMA players reveal potential chromosomal abnormalities in breast cancer cell line

GENIGMA players reveal potential chromosomal abnormalities in breast cancer cell line

More than 36,000 people from around the world are playing an average of 5000 games per day

20
Apr
Wed, 20/04/2022 - 13:00
RESEARCH

New therapeutic target for aggressive blood cancer found

New therapeutic target for aggressive blood cancer found

APL is an aggressive type of blood cancer that is responsible for 5-15% of all types of leukaemia

12
Apr
Tue, 12/04/2022 - 14:19
RESEARCH

Act of sabotage determines mammalian embryonic development

Act of sabotage determines mammalian embryonic development

Study finds evidence that the regulation of alternative splicing, which rarely goes wrong in healthy cells, goes haywire in an unexpected place.

Pages